Covered recipient · General Payments record
MICHELLE KAKU
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$9,307.51
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,685.00 | 2 |
| Food and Beverage | $672.15 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $3,007.03 | 7 |
| ARGENX US, INC. | $249.77 | 2 |
| UCB, Inc. | $77.00 | 2 |
| CSL Behring | $23.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARGENX US, INC. | $124.77 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142117527 | CMS |
| ARGENX US, INC. | $125.00 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142120807 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,611.00 | 01/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105724993 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.49 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105503666 | CMS |
| AstraZeneca Pharmaceuticals LP | $33.81 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105556902 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.98 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104777338 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.72 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104449587 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,074.00 | 05/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104568628 | CMS |
| AstraZeneca Pharmaceuticals LP | $134.03 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104206503 | CMS |
| CSL Behring | $23.35 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134637931 | CMS |
| UCB, Inc. | $39.33 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143051221 | CMS |
| UCB, Inc. | $37.67 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143051223 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.